Literature DB >> 7114093

Review article: mucolipidosis IV.

B F Crandall, M Philippart, W J Brown, D A Bluestone.   

Abstract

We review all reported cases of Mucolipidosis IV, add a new one, and present evidence for a generalized phospholipid storage. All phospholipids were increased in the liver, skin fibroblasts and urine. Lysobisphosphatydic acid which was markedly elevated in these samples was the only lipid stored in muscle. A slowly progressive neurological disease with mental retardation and corneal opacities, but lacking mucopolysaccharide excretion, skeletal changes and organomegaly should raise the suspicion of this disease. At this time, the diagnosis is made by EM studies of skin or conjunctiva which should be done if results of tests on serum or bone marrow for lysosomal diseases are normal. We found some of the typical inclusions in skin fibroblasts from an obligate carrier, which suggests that distinction between the homozygote and heterozygote may be difficult. Despite this, two succeeding pregnancies with normal outcomes were successfully monitored.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7114093     DOI: 10.1002/ajmg.1320120308

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  18 in total

1.  Mucolipidosis type IV: abnormal transport of lipids to lysosomes.

Authors:  R Bargal; G Bach
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

2.  Delayed lysosomal metabolism of lipids in mucolipidosis type IV fibroblasts after LDL-receptor-mediated endocytosis.

Authors:  S M Jansen; J E Groener; W Bax; B J Poorthuis
Journal:  J Inherit Metab Dis       Date:  2001-10       Impact factor: 4.982

3.  Mucolipidosis Type IV Due to Novel MCOLN1 Mutation.

Authors:  Vykuntaraju K Gowda; Varunvenkat M Srinivasan; Maya Bhat; Asha Benakappa
Journal:  Indian J Pediatr       Date:  2017-06-16       Impact factor: 1.967

4.  Mapping of the mucolipidosis type IV gene to chromosome 19p and definition of founder haplotypes.

Authors:  S A Slaugenhaupt; J S Acierno; L A Helbling; C Bove; E Goldin; G Bach; R Schiffmann; J F Gusella
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

5.  LAPTMs regulate lysosomal function and interact with mucolipin 1: new clues for understanding mucolipidosis type IV.

Authors:  Silvia Vergarajauregui; Jose A Martina; Rosa Puertollano
Journal:  J Cell Sci       Date:  2011-01-11       Impact factor: 5.285

Review 6.  Mucolipin 1: endocytosis and cation channel--a review.

Authors:  Gideon Bach
Journal:  Pflugers Arch       Date:  2004-11-27       Impact factor: 3.657

7.  Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV.

Authors:  Bhuvarahamurthy Venugopal; Marsha F Browning; Cyntia Curcio-Morelli; Andrea Varro; Norman Michaud; Nanda Nanthakumar; Steven U Walkley; James Pickel; Susan A Slaugenhaupt
Journal:  Am J Hum Genet       Date:  2007-10-02       Impact factor: 11.025

8.  Identification of the penta-EF-hand protein ALG-2 as a Ca2+-dependent interactor of mucolipin-1.

Authors:  Silvia Vergarajauregui; Jose A Martina; Rosa Puertollano
Journal:  J Biol Chem       Date:  2009-10-28       Impact factor: 5.157

9.  Phospholipids accumulation in mucolipidosis IV cultured fibroblasts.

Authors:  R Bargal; G Bach
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

10.  Ganglioside GM3 sialidase activity in fibroblasts of normal individuals and of patients with sialidosis and mucolipidosis IV. Subcellular distribution and and some properties.

Authors:  M Lieser; E Harms; H Kern; G Bach; M Cantz
Journal:  Biochem J       Date:  1989-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.